Valuation: Allied Corp.

Market Cap 1.3M 1.17M 1.07M 973K 1.82M 124M 1.85M 12.81M 5.14M 65.11M 4.89M 4.79M 205M P/E 2023
-2.13x
P/E 2024 -2.52x
Enterprise Value 7.55M 6.76M 6.22M 5.64M 10.54M 717M 10.73M 74.18M 29.78M 377M 28.34M 27.74M 1.19B EV / Sales 2023
394,366,816x
EV / Sales 2024 171,944,593x
Free-Float
100%
Yield 2023 *
-
Yield 2024 -
1 week+1,109,900.00%
Current month+1,109,900.00%
1 month+1,109,900.00%
3 months+1,109,900.00%
6 months+1,109,900.00%
Current year+2,120.00%
Current year 0
Extreme 1.0E-6
0.01
1 year 0
Extreme 1.0E-6
0.01
3 years 0
Extreme 1.0E-6
0.25
5 years 0
Extreme 1.0E-6
2.15
10 years 0
Extreme 1.0E-6
4.5
Manager TitleAgeSince
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer 71 -
Corporate Officer/Principal - 2020-05-01
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - 2020-05-01
Director/Board Member - 2024-10-20
Date Insider Type Main position Quantity % Market Cap. Importance
4/25/23 Buy

Director

80,000 0.0824%
9/22/20 Buy

Chief Executive Officer

10,000 0.0118%
9/22/20 Other

Chief Executive Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+1,109,900.00%-.--%-92.34% 117
+3.19%+11.31%+64.28%+155.91% 1,263B
-0.73%+3.56%+44.65%+84.17% 658B
+1.41%+3.24%+35.25%+108.88% 521B
+0.42%+3.20%+55.81%+72.50% 391B
+2.18%+2.93%+73.90%+45.59% 369B
+1.12%+4.52%+34.76%+58.24% 307B
+6.96%+8.86%+11.95%+36.20% 290B
+1.15%+6.09%+56.15%+82.25% 252B
+3.06%+9.38%+42.48%+117.32% 212B
Average +1.88%+5.31%+41.92%+66.87% 426.19B
Weighted average by Cap. +2.01%+6.60%+50.51%+100.44%

Financials

2023 2024
Net sales 0.07 0.06 0.06 0.05 0.1 6.85 0.1 0.71 0.28 3.6 0.27 0.26 11.36 0.1 0.09 0.08 0.07 0.13 9.13 0.14 0.94 0.38 4.8 0.36 0.35 15.15
Net income -10.68M -9.56M -8.79M -7.97M -14.9M -1.01B -15.17M -105M -42.1M -533M -40.06M -39.21M -1.68B -3.98M -3.56M -3.28M -2.97M -5.55M -378M -5.65M -39.06M -15.68M -199M -14.92M -14.6M -626M
Net Debt 5.65M 5.06M 4.66M 4.22M 7.89M 537M 8.03M 55.52M 22.29M 282M 21.21M 20.76M 890M 6.25M 5.6M 5.15M 4.66M 8.72M 593M 8.88M 61.38M 24.64M 312M 23.45M 22.95M 984M
Projected Income Statement - Annual - Allied Corp.
Logo Allied Corp.
Allied Corp. is an international medical cannabis production company. The Company is engaged in researching, creating, and producing targeted cannabinoid health solutions. It focuses on the development of Colombian produced medicinal cannabis for patients with conditions potentially suitable for treatment. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder (PTSD), Parkinson’s disease, Tourette’s syndrome, irritable bowel syndrome (IBS) and spasticity associated with multiple sclerosis (MS) and spinal cord injury (SCI). Its core hemp-derived cannabidiol (CBD) brands are Tactical Relief Brand, Equilibrium Bio and MaXXa. The Tactical Relief brand's flagship product is a hemp-derived CBD tincture for sale in the United States. The Equilibrium Bio brand is primarily focused on hydration and recovery areas. The MaXXa brand develops natural CBD-infused cosmetics and beauty products.
Employees
-
  1. Stock Market
  2. Stocks
  3. ALID Stock